openPR Logo
Press release

Intravenous Access Devices Market Rapid Growth By Top Players Becton, Dickinson and Company, B. Braun Melsungen AG, Teleflex, Inc., C.R. Bard, Inc., Fresenius Medical Care, Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., and

11-22-2018 03:46 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Coherent Market Insights

Intravenous Access Devices Market

Intravenous Access Devices Market

Intravenous procedures are highly preferred to treat cardiovascular disease are expected to drive growth of the intravenous access devices market over the forecast period. Key players operating in the market are focusing on development of new intravenous devices for treatment of diabetes and coronary heart disease to expand their market share. According to World Health Organization (WHO), in 2016, around 10% adults out of around 110 million people suffered from diabetes in China. The number is projected to reach around 150 million by 2040.

The manufacturers have opportunity to tap major market share in case of emerging economies, as around 50% percent of population live with undiagnosed lifestyle diseases. For instance, as per WHO, in 2016, around 53% of people suffering from diabetes were undiagnosed in China.

Download PDF Brochure of This Business Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/567

Market Dynamics

Rising incidence of cardiovascular disease due to increase in the prevalence of diabetes, high blood pressure cases and number of smokers worldwide is expected to favor the demand for intravenous access device around the globe.

According to World Health Organization (WHO), in 2015 around 17.7 million people died due to cardiovascular disease worldwide. Furthermore, the majority of deaths are occurred in emerging economies due to high prevalence rate and lack of healthcare services in rural areas.

Also, increasing aging population and rising demand for intravenous access are the other factors leading to the growth of intravenous access device market in developed as well as emerging economies.

As per United Nations Population Fund, people aged 60 years and above accounted for 12.3% of the global population in 2015, which is expected to increase to 22% by 2050. The factors behind aging population in developed region are developed healthcare services and access of healthcare facilities to people, better nutrition, sanitation and economic development.

Competitive Analysis

Some major players operating in the intravenous access devices market includes Becton, Dickinson and Company, B. Braun Melsungen AG, Teleflex, Inc., C.R. Bard, Inc., Fresenius Medical Care, Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., and Baxter International.

Request For Customization Of This Business Research Report: https://www.coherentmarketinsights.com/insight/request-customization/567

Detailed Segmentation:

Global Intravenous Access Devices Market, By Product Type:
IV Catheters
IV Infusion Pumps
IV Needles

Global Intravenous Access Devices Market, By Catheters:
Midline Peripheral Catheters
Peripherally Inserted Central Catheters
Centrally Inserted Central Catheters
Others

Global Intravenous Access Devices Market, By End User:
Hospitals and clinics
Ambulatory surgery centers
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Intravenous Access Devices Market Rapid Growth By Top Players Becton, Dickinson and Company, B. Braun Melsungen AG, Teleflex, Inc., C.R. Bard, Inc., Fresenius Medical Care, Smiths Medical, Hospira, Inc., Covidien Plc, Fresenius Medical Care AG & Co., and here

News-ID: 1392978 • Views:

More Releases from Coherent Market Insights

Radiation Oncology Market Set to Witness Significant Growth by 2025-2032 | Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, Mevion Medical Systems
Radiation Oncology Market Set to Witness Significant Growth by 2025-2032 | Varia …
The global radiation oncology market is estimated to be valued at USD 12.51 Bn in 2025 and is expected to reach USD 16.31 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 11.2% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Radiation Oncology Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth
Medical Oxygen Cylinder Market Share, Revenue, Price, Growth Rate, and Ranking Analysis Report 2025-2032 | Luxfer Gas Cylinders, Catalina Cylinders, Worthington Industries
Medical Oxygen Cylinder Market Share, Revenue, Price, Growth Rate, and Ranking A …
The global medical oxygen cylinder market is estimated to be valued at USD 4.74 Bn in 2025 and is expected to reach USD 6.90 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Medical Oxygen Cylinder Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends,
Organic Skincare Market to reach Blatant Growth in Coming years by 2032 |Shiseido Company Limited, Natura & Co., The Estee Lauder Companies, Yves Rocher
Organic Skincare Market to reach Blatant Growth in Coming years by 2032 |Shiseid …
The global organic skincare market is estimated to be valued at USD 13.56 Bn in 2025 and is expected to reach USD 24.47 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 8.8% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Organic Skincare Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth
Frozen Dessert Market to Witness Massive Growth by 2032 |Nestlé, Unilever, General Mills Inc., Dippin' Dots LLC
Frozen Dessert Market to Witness Massive Growth by 2032 |Nestlé, Unilever, Gen …
The Global Frozen Dessert Market is estimated to be valued at USD 128.56 Bn in 2025 and is expected to reach USD 172.62 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of 4.3% from 2025 to 2032. The latest report from Coherent Market Insights examines the growth prospects of the Frozen Dessert Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth

All 5 Releases


More Releases for Intravenous

Rising Cancer Prevalence Driving The Intravenous Solutions Market: Critical Driv …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Intravenous Solutions Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for intravenous solutions has experienced robust expansion recently and is projected to increase from $14 billion in 2024 to $14.91 billion in 2025, reflecting a compound annual growth rate of 6.5%; this upward
Future Outlook of the Soliris Intravenous Market: Soliris Intravenous Trends and …
The global Soliris Intravenous Market was valued at approximately USD 3.5 billion in 2024 and is projected to reach around USD 6.8 billion by 2033, growing at a compound annual growth rate (CAGR) of about 7.5% from 2025 to 2033. Request a sample copy of this report at: https://www.omrglobal.com/request-sample/soliris-intravenous-market Soliris Intravenous Market Overview: The Soliris Intravenous Market is experiencing steady growth driven by the increasing prevalence of rare and chronic diseases such as
Intravenous Iron Drugs Market
The "Intravenous Iron Drugs Market" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031.  The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Intravenous Iron Drugs Market, 2024-2031 Verified Market Research's most recent report, "Intravenous Iron Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030," provides
Intravenous (IV) Solutions Market
The Global Intravenous (IV) Solution Market is expected to reach USD 11,511.2 million by 2022 and is expected to grow at a CAGR of 7.69% during the forecast period 2016-2022. The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. Key Finding The global Intravenous (IV) Solution market and is expected to reach USD
Intravenous Solutions Market Opportunity Analysis, 2026
Intravenous solutions are the chemically prepared fluids, which are administered in the body through venous circulation to maintain or replace the lost body fluid level. There are various types of IV solutions that have different effects on a human body. Majority of intravenous solutions constitute of solvent and solute out of which solvents are sterile water and solutes are electrolytes such as sodium, potassium, and chloride. Intravenous solutions market is
Intravenous Product Packaging Market -
Global healthcare sector continues to develop at an impressive rate. As a result, packaging marketplace is undergoing huge changes with specialized focus on offering innovative packaging tools/products to pharmaceutical industry. One such core product that offers lucrative market opportunities for packaging companies is intravenous products. Download PDF Brochure For Future Advancements@ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=14075 Intravenous product such as catheters and IV fluid bags are mainly used to prevent and treat various chronic illness